Makoto Inoue

Medicine & Life Sciences

1. 3-(2-methoxybenzylamino)-2-phenylpiperidine 36%
2. 4-hydroxymercuribenzoate 27%
3. Analgesia 49%
4. Analgesics 31%
5. Astrocytes 20%
6. Autoimmune Experimental Encephalomyelitis 91%
7. Bradykinin 49%
8. Capsaicin 57%
9. Cryptococcus 20%
10. Dynorphins 23%
11. Enkephalins 26%
12. Hyperalgesia 42%
13. Immune Reconstitution Inflammatory Syndrome 21%
14. Inflammasomes 63%
15. Injections 28%
16. Interferons 27%
17. kyotorphin 55%
18. lysophosphatidic acid 86%
19. Lysophosphatidic Acid Receptors 75%
20. Morphine 77%
21. Morphine Dependence 32%
22. Multiple Sclerosis 45%
23. Myelinated Nerve Fibers 21%
24. N-Methyl-D-Aspartate Receptors 28%
25. Nerve Endings 36%
26. Neuralgia 100%
27. Neurons 21%
28. nociceptin 81%
29. nociceptin receptor 51%
30. Nociception 84%
31. Nociceptors 62%
32. Oligodeoxyribonucleotides 24%
33. Opioid Analgesics 35%
34. Opioid Receptors 24%
35. Osteopontin 38%
36. Pain 37%
37. Pain Measurement 45%
38. Peripheral Nerves 21%
39. Peripheral Tolerance 31%
40. Pertussis Toxin 21%
41. phosphoramidon 27%
42. Sciatic Nerve 22%
43. Spinal Cord 35%
44. Spinal Injections 19%
45. Substance P 96%
46. T-Lymphocytes 41%
47. Tachykinin Receptors 25%
48. TRPV1 receptor 20%
49. Unmyelinated Nerve Fibers 22%
50. Wounds and Injuries 33%